Agency Forms Undergoing Paperwork Reduction Act Review, 15368-15369 [2013-05523]
Download as PDF
<![CDATA[
15368
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Notices
risk populations including, but not
limited to, those of lower SES, Hispanic,
African American and other ethnic
groups.
NCCDPHP is currently pursuing a key
initiative to improve the efficiency and
effectiveness of CDC project officers
who oversee the state and territorial oral
health programs. An electronic
management information system (MIS)
to support program management,
consulting and evaluation has been
developed in support of the cooperative
agreement. The MIS provides a central
repository of information, such as the
plans of the state or territorial oral
health programs (their goals, objectives,
performance milestones and indicators),
as well as state and territorial oral
health performance activities including
programmatic and financial
information. State oral health programs
have used the MIS to submit their
required semi-annual reports to CDC
(CDC Oral Health Management
Information System, OMB No. 0920–
0739, 5/31/2013). The last report under
the current FOA is due on October 30,
2013.
CDC is requesting OMB approval to
extend clearance for the MIS until
December 31, 2013. Information will be
reported to CDC once during this
period. The extension will allow to CDC
to receive final reports from the state
oral health programs and to provide any
technical assistance or follow-up
support that may be needed to produce
accurate final reports. There is no
change to the estimated burden per
response, which is 11 hours.
All information will be collected
electronically. There are no costs to
respondents other than their time. The
total estimated annualized burden hours
are 220.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
State Oral Health Programs ............................................................................
20
1
11
220
Dated: February 28, 2013.
Ron A. Otten,
Director, Office of Scientific Integrity (OSI),
Office of the Associate Director for Science
(OADS), Office of the Director, Centers for
Disease Control and Prevention.
Management and Budget, Washington,
DC 20503 or by fax to (202) 395–5806.
Written comments should be received
within 30 days of this notice.
[FR Doc. 2013–05518 Filed 3–8–13; 8:45 am]
National Disease Surveillance
Program (OMB No. 0920–0009
Expiration 4/30/2013)—Revision—
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and
Prevention, (CDC).
Proposed Project
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Background and Brief Description
[30Day-13–0009]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call (404) 639–7570 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Formal surveillance of 16 separate
reportable diseases has been ongoing to
meet the public demand and scientific
interest in accurate, consistent,
epidemiologic data. These ongoing
disease reports include: CreutzfeldtJakob Disease (CJD), Cyclosporiasis,
Dengue, Hantavirus, Kawasaki
Syndrome, Legionellosis, Lyme disease,
Malaria, Plague, Q Fever, Reye
Syndrome, Tickborne Rickettsial
Disease, Trichinosis, Tularemia,
Typhoid Fever, and Viral Hepatitis.
Case report forms from state and
territorial health departments enable
CDC to collect demographic, clinical,
and laboratory characteristics of cases of
these diseases. We are requesting
changes to the Legionellois form that
will allow CDC to better detect potential
clusters and outbreaks of Legionnaires’
disease and to monitor changing
epidemiological trends by collecting a
greater level of detail for each
legionellosis case. The burden to the
respondents should be minimally
affected by these proposed changes.
The purpose of the proposed study is
to direct epidemiologic investigations,
identify and monitor trends in
reemerging infectious diseases or
emerging modes of transmission, to
search for possible causes or sources of
the diseases, and develop guidelines for
prevention and treatment. The data
collected will also be used to
recommend target areas most in need of
vaccinations for selected diseases and to
determine development of drug
resistance. Because of the distinct
nature of each of the diseases, the
number of cases reported annually is
different for each. There is no cost to
respondents other than their time. The
total burden requested is 11,447 hours.
mstockstill on DSK4VPTVN1PROD with NOTICES
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
VerDate Mar<15>2010
.................................................
.................................................
.................................................
.................................................
.................................................
.................................................
16:19 Mar 08, 2013
Number of
respondents
Form name
Jkt 229001
CJD ................................................................
Cyclosporiasis ................................................
Dengue ...........................................................
Hantavirus ......................................................
Kawasaki Syndrome ......................................
Legionellosis ...................................................
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
E:\FR\FM\11MRN1.SGM
Number of
responses per
respondent
20
55
55
46
55
23
11MRN1
2
10
182
3
8
12
Average
burden per
response
(in hrs)
20/60
15/60
15/60
20/60
15/60
20/60
15369
Federal Register / Vol. 78, No. 47 / Monday, March 11, 2013 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondent
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
Epidemiologist
.................................................
.................................................
.................................................
.................................................
.................................................
.................................................
.................................................
.................................................
.................................................
.................................................
Dated: February 28, 2013.
Ron A. Otten,
Director, Office of Scientific Integrity (OSI),
Office of the Associate Director for Science
(OADS), Office of the Director, Centers for
Disease Control and Prevention.
[FR Doc. 2013–05523 Filed 3–8–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK4VPTVN1PROD with NOTICES
Board of Scientific Counselors, Office
of Public Health Preparedness and
Response (BSC, OPHPR)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Times and Dates:
April 2, 2013 9:30 a.m.–3:00 p.m.
(BSC, OPHPR meeting)
April 3, 2013 8:30 a.m.–3:30 p.m.
(Joint meeting of the BSC, OPHPR and
the National Biodefense Science Board
[NBSB])
Place: CDC, 1600 Clifton Road NE.,
Roybal Campus, Building 19, Room 256
Atlanta, Georgia 30329.
Status: Open to the public limited
only by the space available. The meeting
room will accommodate up to 30
people. Public participants should preregister for the meeting as described in
Additional Information for Public
Participants.
Purpose: This Board is charged with
providing advice and guidance to the
Secretary, Department of Health and
Human Services (HHS), the Assistant
Secretary for Health (ASH), the Director,
Centers for Disease Control and
Prevention (CDC), and the Director,
Office of Public Health Preparedness
and Response (OPHPR), concerning
VerDate Mar<15>2010
16:19 Mar 08, 2013
Number of
respondents
Form name
Jkt 229001
Lyme Disease ................................................
Malaria ............................................................
Plague ............................................................
Q Fever ..........................................................
Reye Syndrome .............................................
Tick-borne Rickettsia ......................................
Trichinosis ......................................................
Tularemia .......................................................
Typhoid Fever ................................................
Viral hepatitis ..................................................
strategies and goals for the programs
and research within OPHPR, monitoring
the overall strategic direction and focus
of the OPHPR Divisions and Offices,
and administration and oversight of
peer review of OPHPR scientific
programs. For additional information
about the Board, please visit: https://
www.cdc.gov/phpr/science/
counselors.htm.
Matters To Be Discussed: Agenda
items for this meeting include: (1)
Briefings and BSC deliberation on the
following topics: Public Health
Preparedness and Response Policy
Updates; improving critical information
sharing across CDC; biosecurity risk
evaluation software; measuring
operational readiness; (2) BSC liaison
representative updates to the Board
highlighting organizational activities
relevant to the OPHPR mission. Day 2
of the meeting will include a joint
Federal Advisory Committee briefing
with NBSB, deliberation and vote on the
recommendations and report written by
the joint BSC, OPHPR–NBSB Strategic
National Stockpile ad hoc working
group. [The National Biodefense
Science Board (NBSB) was created
under the authority of the Pandemic and
All-Hazards Preparedness Act, signed
into law on December 19, 2006. The
Board is a FACA committee utilized by
the Office of the Assistant Secretary for
Preparedness and Response. The NBSB
was established to provide expert advice
and guidance to the Secretary of the
U.S. Department of Health and Human
Services (HHS) on scientific, technical,
and other matters of special interest to
HHS regarding activities to prevent,
prepare for, and respond to adverse
health effects of public health
emergencies resulting from chemical,
biological, nuclear, and radiological
events, whether naturally occurring,
accidental, or deliberate.]
Agenda items are subject to change as
priorities dictate.
PO 00000
Frm 00029
Fmt 4703
Sfmt 9990
Number of
responses per
respondent
52
55
11
55
50
55
25
55
55
55
Average
burden per
response
(in hrs)
385
20
1
1
1
18
1
2
6
200
10/60
15/60
20/60
10/60
20/60
10/60
20/60
20/60
20/60
25/60
Additional Information for Public
Participants: Members of the public that
wish to attend this meeting should preregister by submitting the following
information by email, facsimile, or
phone (see Contact Person for More
Information) no later than 12:00 noon
(EDT) on Monday, March 25, 2013:
• Full Name,
• Organizational Affiliation,
• Complete Mailing Address,
• Citizenship, and
• Phone Number or Email Address
Contact Person for More Information:
Marquita Black, Office of Science and
Public Health Practice Executive
Assistant, Centers for Disease Control
and Prevention, 1600 Clifton Road NE.,
Mailstop D–44, Atlanta, Georgia 30333,
Telephone: (404) 639–7325; Facsimile:
(404) 639–7977; Email:
OPHPR.BSC.Questions@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention, and Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2013–05561 Filed 3–8–13; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\11MRN1.SGM
11MRN1
]]>Agencies
[Federal Register Volume 78, Number 47 (Monday, March 11, 2013)]
[Notices]
[Pages 15368-15369]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-05523]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-13-0009]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
(404) 639-7570 or send an email to omb@cdc.gov. Send written comments
to CDC Desk Officer, Office of Management and Budget, Washington, DC
20503 or by fax to (202) 395-5806. Written comments should be received
within 30 days of this notice.
Proposed Project
National Disease Surveillance Program (OMB No. 0920-0009 Expiration
4/30/2013)--Revision--National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention, (CDC).
Background and Brief Description
Formal surveillance of 16 separate reportable diseases has been
ongoing to meet the public demand and scientific interest in accurate,
consistent, epidemiologic data. These ongoing disease reports include:
Creutzfeldt-Jakob Disease (CJD), Cyclosporiasis, Dengue, Hantavirus,
Kawasaki Syndrome, Legionellosis, Lyme disease, Malaria, Plague, Q
Fever, Reye Syndrome, Tickborne Rickettsial Disease, Trichinosis,
Tularemia, Typhoid Fever, and Viral Hepatitis. Case report forms from
state and territorial health departments enable CDC to collect
demographic, clinical, and laboratory characteristics of cases of these
diseases. We are requesting changes to the Legionellois form that will
allow CDC to better detect potential clusters and outbreaks of
Legionnaires' disease and to monitor changing epidemiological trends by
collecting a greater level of detail for each legionellosis case. The
burden to the respondents should be minimally affected by these
proposed changes.
The purpose of the proposed study is to direct epidemiologic
investigations, identify and monitor trends in reemerging infectious
diseases or emerging modes of transmission, to search for possible
causes or sources of the diseases, and develop guidelines for
prevention and treatment. The data collected will also be used to
recommend target areas most in need of vaccinations for selected
diseases and to determine development of drug resistance. Because of
the distinct nature of each of the diseases, the number of cases
reported annually is different for each. There is no cost to
respondents other than their time. The total burden requested is 11,447
hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondent Form name respondents responses per response (in
respondent hrs)
----------------------------------------------------------------------------------------------------------------
Epidemiologist........................ CJD..................... 20 2 20/60
Epidemiologist........................ Cyclosporiasis.......... 55 10 15/60
Epidemiologist........................ Dengue.................. 55 182 15/60
Epidemiologist........................ Hantavirus.............. 46 3 20/60
Epidemiologist........................ Kawasaki Syndrome....... 55 8 15/60
Epidemiologist........................ Legionellosis........... 23 12 20/60
[[Page 15369]]
Epidemiologist........................ Lyme Disease............ 52 385 10/60
Epidemiologist........................ Malaria................. 55 20 15/60
Epidemiologist........................ Plague.................. 11 1 20/60
Epidemiologist........................ Q Fever................. 55 1 10/60
Epidemiologist........................ Reye Syndrome........... 50 1 20/60
Epidemiologist........................ Tick-borne Rickettsia... 55 18 10/60
Epidemiologist........................ Trichinosis............. 25 1 20/60
Epidemiologist........................ Tularemia............... 55 2 20/60
Epidemiologist........................ Typhoid Fever........... 55 6 20/60
Epidemiologist........................ Viral hepatitis......... 55 200 25/60
----------------------------------------------------------------------------------------------------------------
Dated: February 28, 2013.
Ron A. Otten,
Director, Office of Scientific Integrity (OSI), Office of the Associate
Director for Science (OADS), Office of the Director, Centers for
Disease Control and Prevention.
[FR Doc. 2013-05523 Filed 3-8-13; 8:45 am]
BILLING CODE 4163-18-P
